Protagenic Therapeutics Inc. (PTIXW) Business News Dec. 09, 2025, 13:46 UTC Results from Phase 1 Multiple-Dose Study of PT00114 Full text
Register to leave comments News bot Dec. 9, 2025, 1:50 p.m. 📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (17%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (17%) **Content type:** Clinical